title: Craving in alcohol-dependent patients after detoxification is related to glutamatergic dysfunction in the nucleus accumbens and the anterior cingulate cortex.
abstract: The upregulation of glutamatergic excitatory neurotransmission is thought to be partly responsible for the acute withdrawal symptoms and craving experienced by alcohol-dependent patients. Most physiological evidence supporting this hypothesis is based on data from animal studies. In addition, clinical data show that GABAergic and anti-glutamatergic drugs ameliorate withdrawal symptoms, offering indirect evidence indicative of glutamatergic hyperexcitability in alcohol-dependent subjects. We used proton magnetic resonance spectroscopy to quantify the glutamate (Glu) levels in healthy control subjects and in alcohol-dependent patients immediately after detoxification. The volumes of interest were located in the nucleus accumbens (NAcc) and the anterior cingulate cortex (ACC), which are two brain areas that have important functions in reward circuitry. In addition to Glu, we quantified the levels of combined Glu and glutamine (Gln), N-acetylaspartate, choline-containing compounds, and creatine. The Glu levels in the NAcc were significantly higher in patients than in controls. Craving, which was measured using the Obsessive Compulsive Drinking Scale, correlated positively with levels of combined Glu and Gln in the NAcc and in the ACC. The levels of all other metabolites were not significantly different between patients and controls. The increased Glu levels in the NAcc in alcohol-dependent patients shortly after detoxification confirm the animal data and suggest that striatal glutamatergic dysfunction is related to ethanol withdrawal. The positive correlation between craving and glutamatergic metabolism in both key reward circuitry areas support the hypothesis that the glutamatergic system has an important role in the later course of alcohol dependence with respect to abstinence and relapse.
authors: Department of Psychiatry, University of Muenster, Muenster, Germany.
authors: Jochen
authors: J
authors: Bauer
authors: Anya
authors: A
authors: Pedersen
authors: Norbert
authors: N
authors: Scherbaum
authors: Johanna
authors: J
authors: Bening
authors: Johanna
authors: J
authors: Patschke
authors: Harald
authors: H
authors: Kugel
authors: Walter
authors: W
authors: Heindel
authors: Volker
authors: V
authors: Arolt
authors: Patricia
authors: P
authors: Ohrmann
mesh_terms: D000328:Adult; D000437:Alcoholism / Q000175:diagnosis / Q000378:metabolism* / Q000628:therapy; D016739:Behavior, Addictive / Q000175:diagnosis / Q000378:metabolism* / Q000628:therapy; D005260:Female; D018698:Glutamic Acid / Q000378:metabolism*; D006179:Gyrus Cinguli / Q000378:metabolism*; D006801:Humans; D009682:Magnetic Resonance Spectroscopy / Q000379:methods; D008297:Male; D008875:Middle Aged; D009714:Nucleus Accumbens / Q000378:metabolism*; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis / Q000378:metabolism* / Q000628:therapy; D011795:Surveys and Questionnaires
chemical_list: D018698:Glutamic Acid
references: Arch Gen Psychiatry. 2010 Sep;67(9):946-54
references: 20603446
references: Ann N Y Acad Sci. 2003 Nov;1003:196-211
references: 14684447
references: Alcohol Clin Exp Res. 1995 Feb;19(1):92-9
references: 7771669
references: Pharmacopsychiatry. 2007 Mar;40(2):64-7
references: 17447175
references: Addict Biol. 2013 Mar;18(2):379-91
references: 22070867
references: Alcohol Clin Exp Res. 2005 Jan;29(1):150-158
references: 15895489
references: Ann N Y Acad Sci. 2010 Feb;1187:148-71
references: 20201852
references: Alcohol Clin Exp Res. 2007 Apr;31(4):604-11
references: 17374039
references: Neuropharmacology. 2012 Jun;62(8):2480-8
references: 22616110
references: Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1709-13
references: 21616118
references: Addiction. 1993 Jun;88(6):791-804
references: 8329970
references: J Psychopharmacol. 2008 Jan;22(1):11-23
references: 18187529
references: J Magn Reson Imaging. 2011 Sep;34(3):645-52
references: 21761460
references: Mol Psychiatry. 2011 Oct;16(10):974-86
references: 21519339
references: Neuroscience. 1999;93(3):1135-40
references: 10473277
references: Ann N Y Acad Sci. 1999 Jun 29;877:49-63
references: 10415642
references: NMR Biomed. 2011 Oct;24(8):943-57
references: 21882281
references: Magn Reson Med. 2008 Oct;60(4):964-9
references: 18816817
references: Neuron. 2004 Sep 30;44(1):161-79
references: 15450168
references: Alcohol Alcohol. 2009 Mar-Apr;44(2):128-35
references: 19155229
references: Neuroscience. 2007 May 25;146(3):1259-74
references: 17391856
references: J Abnorm Psychol. 2001 Feb;110(1):40-8
references: 11261398
references: Alcohol Alcohol. 2004 Jul-Aug;39(4):357-61
references: 15208171
references: Neuroreport. 2007 Sep 17;18(14):1511-4
references: 17712285
references: Biochem Pharmacol. 2008 Jan 1;75(1):218-65
references: 17706608
references: Biol Psychiatry. 2010 May 1;67(9):812-22
references: 19897175
references: Neuropsychopharmacology. 2011 Jun;36(7):1359-65
references: 21389979
references: Alcohol Alcohol. 2011 Jul-Aug;46(4):373-82
references: 21478495
references: Magn Reson Med. 1993 Dec;30(6):672-9
references: 8139448
references: Arch Gen Psychiatry. 1996 Mar;53(3):225-31
references: 8611059
references: Neuropsychopharmacology. 2007 Jan;32(1):103-9
references: 16452988
references: Biol Psychiatry. 2012 Jun 1;71(11):1015-21
references: 21907974
references: Addict Behav. 2004 Sep;29(7):1325-39
references: 15345268
references: Brain Res. 2007 Feb 23;1134(1):148-61
references: 17198693
references: Eur J Pharmacol. 1999 Jun 4;373(2-3):153-61
references: 10414434
references: Biol Psychiatry. 2010 May 1;67(9):846-54
references: 20044076
references: Front Syst Neurosci. 2011 Nov 24;5:94
references: 22275885
references: Addict Biol. 2010 Apr;15(2):169-84
references: 20148778
references: Alcohol Clin Exp Res. 2011 Dec;35(12):2193-201
references: 21919920
references: NMR Biomed. 2013 Feb;26(2):164-72
references: 22761057
references: Biol Psychiatry. 2005 Dec 15;58(12):974-80
references: 16084857
references: Pharmacol Biochem Behav. 2000 Feb;65(2):345-50
references: 10672989
references: Eur J Radiol. 2011 Jul;79(1):96-100
references: 20022190
references: Subst Abuse Treat Prev Policy. 2011 Jun 28;6:14
references: 21711505
references: J Magn Reson Imaging. 2009 Nov;30(5):1155-62
references: 19856449
references: Arch Gen Psychiatry. 2010 Oct;67(10):1069-77
references: 20921123
references: Alcohol Clin Exp Res. 2005 Jun;29(6):1027-34
references: 15976529
references: PLoS One. 2012;7(5):e36572
references: 22629317
references: Physiol Rev. 2009 Apr;89(2):649-705
references: 19342616